Skip to main content

Table 3 Acute toxicities during treatment

From: Safety and efficacy analysis of chemoradiotherapy/radiotherapy combined with nimotuzumab for treating unresectable oesophageal squamous cell carcinoma in elderly patients: a retrospective analysis

Item

Grade 1–2

≥ Grade 3

NRT (n = 28)

NCRT (n = 26)

Total (n = 54)

NRT (n = 28)

NCRT (n = 26)

Total (n = 54)

Leukopenia

19 (67.86%)

15 (57.69%)

34 (62.96%)

2 (7.14%)

6 (23.08%)

8 (14.81%)

Anemia

10 (35.71%)

13 (50.00%)

23 (42.59%)

0 (0)

0 (0)

0 (0)

Thrombocytopenia

4 (14.29%)

8 (30.77%)

12 (22.22%)

1 (3.57%)

4 (15.38%)

5 (9.26%)

Hyponatremia

5 (17.86%)

3 (11.54%)

8 (14.81%)

2 (7.14%)

2 (7.69%)

4 (7.41%)

Hypoproteinemia

27 (96.43%)

24 (92.31%)

51 (94.44%)

0 (0)

0 (0)

0 (0)

Nausea

6 (21.43%)

12 (46.15%)

18 (33.33%)

0 (0)

0 (0)

0 (0)

Fatigue

25 (89.29%)

22 (84.62%)

47 (87.04%)

0 (0)

0 (0)

0 (0)

Esophagitis

25 (89.29%)

25 (96.15%)

50 (92.59%)

2 (7.14%)

1 (3.85%)

3 (5.56%)

Pneumonia

8 (28.57%)

17 (65.38%)

25 (46.30%)

1 (3.57%)

3 (11.54%)

4 (7.41%)

Fever

2 (7.14%)

4 (15.38%)

6 (11.11%)

0 (0)

0 (0)

0 (0)